L

Lytix Biopharma AS
OSE:LYTIX

Watchlist Manager
Lytix Biopharma AS
OSE:LYTIX
Watchlist
Price: 6.88 NOK 0.88% Market Closed
Market Cap: 341.3m NOK
Have any thoughts about
Lytix Biopharma AS?
Write Note

Lytix Biopharma AS
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lytix Biopharma AS
EPS (Diluted) Peer Comparison

Comparables:
HBC
B
BGBIO
AZT
N
NYKD
T
TRMED

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
L
Lytix Biopharma AS
OSE:LYTIX
EPS (Diluted)
-kr2
CAGR 3-Years
-26%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
EPS (Diluted)
kr0
CAGR 3-Years
4%
CAGR 5-Years
-1%
CAGR 10-Years
5%
B
Bergenbio ASA
OSE:BGBIO
EPS (Diluted)
-kr4
CAGR 3-Years
-118%
CAGR 5-Years
-62%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
EPS (Diluted)
kr0
CAGR 3-Years
-39%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
N
Nykode Therapeutics ASA
OSE:NYKD
EPS (Diluted)
$0
CAGR 3-Years
N/A
CAGR 5-Years
-6%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
EPS (Diluted)
kr0
CAGR 3-Years
66%
CAGR 5-Years
53%
CAGR 10-Years
26%

See Also

What is Lytix Biopharma AS's EPS (Diluted)?
EPS (Diluted)
-2.2 NOK

Based on the financial report for Dec 31, 2023, Lytix Biopharma AS's EPS (Diluted) amounts to -2.2 NOK.

What is Lytix Biopharma AS's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-6%

Over the last year, the EPS (Diluted) growth was -55%. The average annual EPS (Diluted) growth rates for Lytix Biopharma AS have been -26% over the past three years , -6% over the past five years .

Back to Top